Fangfang Lü
- Oncology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Molecular Biology
- Cancer Research
- Pathology and Forensic Medicine
- Topics
- Cancer Treatment and Pharmacology (2 papers)Angiogenesis and VEGF in Cancer (1 paper)HER2/EGFR in Cancer Research (1 paper)
- Partner nations
- China
In The Last Decade
Fangfang Lü
4 papers receiving 452 citations
Peers
Comparison fields: 5 of 53
- Oncology 238
- Pulmonary and Respiratory Medicine 217
- Molecular Biology 151
- Cancer Research 85
- Pathology and Forensic Medicine 84
Countries citing papers authored by Fangfang Lü
This map shows the geographic impact of Fangfang Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangfang Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangfang Lü more than expected).
Fields of papers citing papers by Fangfang Lü
This network shows the impact of papers produced by Fangfang Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangfang Lü. The network helps show where Fangfang Lü may publish in the future.
Co-authorship network of co-authors of Fangfang Lü
This figure shows the co-authorship network connecting the top 25 collaborators of Fangfang Lü. A scholar is included among the top collaborators of Fangfang Lü based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangfang Lü. Fangfang Lü is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 14 | |
| 2 | 436 | |
| 3 | 6 | |
| 4 | 2 |
About Fangfang Lü
Fangfang Lü is a scholar working on Otorhinolaryngology, Hepatology and Oncology, having authored 4 papers that have together received 458 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (2 papers), Angiogenesis and VEGF in Cancer (1 paper) and HER2/EGFR in Cancer Research (1 paper). The work is most often cited by research in Hepatology (72 citations), Oncology (238 citations) and Pulmonary and Respiratory Medicine (217 citations). Fangfang Lü has collaborated with scholars based in China. Frequent co-authors include Yongping Xu, Jin Li, Haitian Quan, Shu Tian, Liguang Lou, Haiyi Guo, Chengying Xie, Li Zhu, Hongxiang Gao and Xi Mo. Their work appears in journals such as Cancer Science, Anti-Cancer Drugs and Interactive Cardiovascular and Thoracic Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.